Strasbourg, France and Montreal-based biopharmaceutical company Domain Therapeutics has raised $42 million in Series A financing.
Company Information
Company
Domain Therapeutics
Location
Strasbourg, Grand Est, France
About
Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Strasbourg